Publications by authors named "Andreu Llorente"

Claim this Profile
C
Core binding factor acute myeloid leukemia: the impact of age, leukocyte count, molecular findings, and minimal residual disease.
Montserrat Hoyos, Josep F Nomdedeu, Jordi Esteve, Rafael Duarte, Josep M Ribera, Andreu Llorente

Eur J Haematol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status: final results of a phase 2 study (Burkimab).
Josep-Maria Ribera, Olga García, Carlos Grande, Jordi Esteve, Albert Oriol, Andreu Llorente

Cancer· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new modified prophylactic scheme against liposomal cytarabine-induced arachnoiditis in adult patients with lymphoma.
Blanca Sanchez-Gonzalez, Andreu Llorente, Juan Manuel Sancho, Carlos Panizo, Jose M Guinea

Leuk Lymphoma· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mortality risk factors in patients with zygomycosis: a retrospective and multicentre study of 25 cases.
Andreu Llorente, Ignacio Perez-Valero, E García, I Heras, V Fraile

Enferm Infecc Microbiol Clin· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophil CD64 expression as marker of bacterial infection: a systematic review and meta-analysis.
Joan Cid, Reyes Aguinaco, Rafael Sánchez, Graciano García-Pardo, Andreu Llorente

J Infect· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of low platelet counts by optical, impedance, and CD61-immunoplatelet methods: estimation of possible inappropriate platelet transfusion.
Joan Cid, Janilson Do Nascimento, Ana Vicent, Reyes Aguinaco, Lourdes Escoda, Andreu Llorente

Transfusion· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia.
Mariano Monzo, Salut Brunet, Alvaro Urbano-Ispizua, Alfons Navarro, Granada Perea, Andreu Llorente

Blood· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postpartum ovarian vein thrombosis.
Xavier Ortín, Arancha Ugarriza, Rosa Ma Espax, Jordi Boixadera, Andreu Llorente

Thromb Haemost· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Cutaneous plasmacytomas following treatment of IgA kappa multiple myeloma].
Xavier Ortín, Andreu Llorente, Salomé Martínez, Aránzazu Ugarriza

Med Clin (Barc)· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ETO sequence may be dispensable in some AML1-ETO leukemias.
Adriana Lasa, Josep F Nomdedeu, Maria J Carnicer, Andreu Llorente, Jorge Sierra

Blood· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrovascular nodules in a patient with leukostasis.
Xavier Ortin, Joan Cid, Andreu Llorente, Tomas Sempere, Arantxa Ugarriza

Transfusion· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis